About OBI Medical
OBI Medical is a company based in Hadsund (Denmark) founded in 2002. OBI Medical has raised $3.23 million across 4 funding rounds from investors including Market Maturation Fund and Danmarks Eksport- og Investeringsfond. The company has 1 employees as of December 31, 2021. OBI Medical operates in a competitive market with competitors including Genalyte, Enumera Molecular, Lyfas, Attomarker and Adsys, among others.
- Headquarter Hadsund, Denmark
- Employees 1 as on 31 Dec, 2021
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Obi Aps
-
Annual Revenue
$116.01 K (USD)-59as on Dec 31, 2019
-
Net Profit
-$389.74 K (USD)-25as on Dec 31, 2020
-
EBITDA
Not available
-
Total Equity Funding
$3.23 M (USD)
in 4 rounds
-
Latest Funding Round
$596.22 K (USD), Seed
Apr 12, 2019
-
Investors
Market Maturation Fund
& 1 more
-
Employee Count
1
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OBI Medical
OBI Medical has successfully raised a total of $3.23M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $596.22 thousand completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OBI Medical
OBI Medical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Market Maturation Fund and Danmarks Eksport- og Investeringsfond.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provision of financing, loans, equity, and insurance for Danish export and investment activities.
|
Locked | Locked | Locked |
Investor details for OBI Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OBI Medical
Investment portfolio details for OBI Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OBI Medical
Detailed financials for OBI Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Obi Medical Comparisons
Peer comparison for OBI Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OBI Medical
OBI Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genalyte, Enumera Molecular, Lyfas, Attomarker and Adsys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicon photonics-based multiplexing tools for biomolecular detection are developed.
|
|
| Locked | Locked | Locked |
Liquid biopsy tools are developed for biomolecule assessment.
|
|
| Locked | Locked | Locked |
Provider of AI-based predictive and preventive digital health test and home remedy
|
|
| Locked | Locked | Locked |
Provider of at-home Covid diagnostic testing services
|
|
| Locked | Locked | Locked |
Provider of AI-based device for rapid blood diagnosis
|
|
| Locked | Locked | Locked |
Develops sensors for medical diagnosis through breath analysis.
|
Detailed competitors of OBI Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Obi Medical
Complete news archive for OBI Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OBI Medical
OBI Medical was founded in 2002 and raised its 1st funding round 11 years after it was founded.
OBI Medical is headquartered in Hadsund, Denmark.
OBI Medical is a funded company, having raised a total of $3.23M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at OBI Medical is 1.
Annual revenue of OBI Medical is $116.01K as on Dec 31, 2019.
OBI Medical was founded in 2002 in Hadsund, Denmark, within the medical software sector. Calculations of arterial acid-base and blood gas status are performed using peripheral venous blood measurements alongside SpO2 data. The v-TAC software is utilized to generate reports that incorporate patient details, entered SpO2 values, derived arterial results, and initial venous measurements from blood gas analyzers. Operations focus on diagnostic tools for clinical settings.
OBI Medical's top competitors include Genalyte, Lyfas and Attomarker.
OBI Medical has 2 investors. Key investors include Market Maturation Fund, and Danmarks Eksport- og Investeringsfond.
The valuation of OBI Medical is $1.54M as of Apr 2019.